Alerus director granted 1,772 ALRS shares
Alerus Financial Corp director John Uribe reported an acquisition of company stock as part of his annual board compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alerus Financial Corp director John Uribe reported an acquisition of company stock as part of his annual board compensation. He received 1,772 shares of Common Stock on May 22, 2026 in a grant or award transaction at a stated price of $0.00 per share.
After this award, Uribe directly holds 7,352 shares of Alerus Financial Corp common stock. The filing notes that his holdings now include 1,772 shares of restricted stock issued under the Alerus Financial Corporation 2019 Equity Incentive Plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,772 | $0.00 | $0.00 |
Footnotes (2)
- F1. All shares were acquired pursuant to an annual director award issued under the Alerus Financial Corporation 2019 Equity Incentive Plan.
- F2. Includes 1,772 shares of restricted stock.
Key Figures
Key Terms
restricted stock financial
annual director award financial
2019 Equity Incentive Plan financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ALRS director John Uribe report on this Form 4?
Was John Uribe’s ALRS transaction an open-market purchase or a compensation grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.